Number of infections per underlying disorder per year

Slides:



Advertisements
Similar presentations
Aspergillosis in AIDS David W. Denning
Advertisements

Chronic pulmonary aspergillosis
The burden of invasive and serious fungal disease in the UK Denning DW 1, Pegorie M 2, Welfare W 2,3 24th European Congress of Clinical Microbiology and.
Pneumonia: Past and Present
Airborne fungi infections Dr David W. Denning FRCP FRCPath Scientific Advisor to the Fungal Research Trust Clinician, Wythenshawe Hospital Head, Antifungal.
Discussion & Limitations Whereas the number of candidaemia cases and AIDS defining fungal infection in HIV patients are systematically surveyed, most fungal.
Wisconsin HIV/AIDS Surveillance Annual Review: Slide Set New diagnoses, prevalent cases, and deaths through December 2014 April 2015 P Wisconsin.
Burden of Serious Fungal Infections in Argentina Roxana G. Vitale, David W Denning Hospital Ramos Mejía and CONICET; Buenos Aires, Argentina; Manchester.
Conclusion Estimating the burden of fungal disease in Vietnam ResultsBackground Methods The prevalence of fungal infections in Vietnam is poorly described,
Amref Health Africa in Kenya Spatial Relationship between TB Infection and Population, Poverty and HIV/AIDs in Kenya Presenter Titus Kiptai AMREF Kenya.
10 year Roadmap by 2025 David W. Denning President GAFFI The University of Manchester.
EQUI - TB Knowledge Programme Quality Assured TB Care for Poor People in Resource Constrained settings 2001 – 2006 Purpose: To promote implementation of.
Burden of Serious Fungal Infections in the Czech Republic Ales Chrdle a, Nada Mallatova b, David W Denning c Objectives We have estimated the number of.
Estimating the Burden of Serious Fungal Diseases in Thailand Methee Chayakulkeeree 1, David W. Denning 2* 1 Division of Infectious Diseases and Tropical.
Carbon monoxide and nitrogen dioxide in the atmosphere: A look at the effects on chronic obstructive pulmonary disease Carbon monoxide and nitrogen dioxide.
* rate for adult females only The burden of serious fungal diseases in Madagascar Rivo Andry Rakotoarivelo, 1 Voahangy Rasolofo Razanamparany, 2 Jocelyn.
Maria N. Gamaletsou 1,2, David Denning 1, and Nikolaos V. Sipsas 2 1 The National Aspergillosis Centre, University Hospital of South Manchester and The.
THE BURDEN OF SERIOUS FUNGAL INFECTIONS IN VENEZUELA Maribel Dolande 1, María Mercedes Panizo 1, Giuseppe Ferrara 1, Víctor Alarcón 1, Nataly García 1,
OBJECTIVEMETHODSRESULTS BURDEN OF SERIOUS FUNGAL INFECTIONS IN SERBIA Valentina Arsic Arsenijevic 1, Sandra Sipetic Grujicic 2, Marina Pekmezovic 1, David.
Strategic Information and the Control of Tuberculosis Brian Williams and Chris Dye TB programme, Monitoring and Evaluation, WHO.
The burden of serious fungal infections in Portugal Raquel Sabino 1, Cristina Verissímo C 1, Célia Pais 2, David W. Denning 3 1 Nacional Institute of Health.
* rate for adult females only An estimation of burden of serious fungal infections in France Jean-Pierre Gangneux 1, Marie-Elisabeth Bougnoux 2, Cendrine.
The Medical Research Council Presentation to the Portfolio Committee on Science and Technology March 16, 2005
COPD Local Burden. Population Prevalence of GOLD Stage I and Stage II & Doctor Diagnosed COPD in Manila, Philippines Source: BOLD Study, 2007;Dantes R.
Correspondence: Bustamante, B: Campos PE: Denning DW:
COPD Local Burden The Philippines. COPD A Global Health Concern COPD a growing cause of morbidity & mortality worldwide 5 th leading cause of death (2002)
Fungal infection accounts for significant rates of morbidity and mortality; however, there is paucity of systematic data on the incidence and prevalence.
The burden of serious fungal diseases in Japan Koichi Izumikawa 1, Masato Tashiro 1, Takahiro Takazono 1, Shintaro Kurihara 1, Tomomi Saijo 2, Kazuko Yamamoto.
PREVALENCE OF OSTEOMYELITIS IN HIV INFECTED PATIENTS. PRESENTERS: 1. MOHAMED M. NOORANY- MBChB V (MUSOM) 2. MUKOYA AQUINATA (Sr)- MBChB V (MUSOM) FACILITATORS:
Increasing Tuberculosis Prevalence in South African Township Associated With Increasing HIV Prevalence Slideset on: Lawn SD, Bekker LG, Middelkoop K, Myer.
Malawi National Cancer Registry update SJD Chasimpha Malawi Cancer Symposium Lilongwe August, 2016.
HIV and NCD overview 21 st International AIDS Conference Durban 2106 Dr Tolu Oni Senior Lecturer & Public Health Medical Specialist University of Cape.
Fungal diseases in the UK
Worldwide availability and pricing of antifungal drugs
Estimated burden of fungal infections in Italy
Estimating serious fungal disease burden in the Philippines
Number of infections per underlying disorder per year
Pengjun Lu, PhD, MPH;1 Kathy Byrd, MD, MPH;2
Chronic respiratory diseases: burden, population and interventions,
The Medical Research Council
Sutapa Agrawal1, Shah Ebrahim1,2
Respiratory diseases caused by fungi
Universidad Militar Nueva Granada, School of Medicine
Somali Federal Republic Ministry of Health
Health Care for the Homeless and Hepatitis National Hepatitis Coordinators' Conference January 27, 2003 Presented by: Amy M. Taylor, MD, MHS Deputy Chief,
Nathan D. Culver, Pharm.D., BCPS; Hera Saleem, Student Pharmacist;
Nazir Ismail CTB/NICD & WHO-SRL & UP
Esophageal Squamous Cell Carcinoma (ESCC) Update
HSEC OCCUPATIONAL HEALTH TRIPARTITE 29 NOVEMBER 2017
Dr Paul T Francis, MD Community Medicine College of Medicine, Zawia
Valley Fever (Coccidioidomycosis) Incidence of Valley Fever in the US.
8th Advances Against Aspergillosis international conference
Tiffany G. Harris, PhD, MS Director of Strategic Information
How common are fungal diseases?
Incidence or Prevalence, per 100,000 Burden, no. of cases per year*
M. Inghammar, G. Engström, G. Kahlmeter, B. Ljungberg, C. -G
Table 7.3: Age-adjusted Death Rates, Selected Causes, by Race, 2014
Prior authorization and patient cost-sharing are least likely to be seen as effective in reducing unnecessary care. “How effective do you think each of.
8th Advances Against Aspergillosis international conference
The HIV Epidemic among People who Inject Drugs
Cryptococcosis: Epidemiology of cryptococcal disease
Indian Scenario HIV Situation TB Situation
Strengthening data collection on
Cryptococcosis: Epidemiology of cryptococcal disease
GloCal Alumni Presentation, April 2019 Building local research capacity for sustainable research practices in LMIC : Experience from Tanzania.
Asthma, a chronic inflammatory disorder of the airways, is one of the more prevalent chronic conditions in Canada.1 According to the 2009/10 Canadian Community.
Schematic diagram of the shared subgroups between asthma and chronic obstructive pulmonary disease (COPD). Schematic diagram of the shared subgroups between.
Classification of allergic fungal disease in asthma.
The Medical Research Council
Public Health Implications
Presentation transcript:

Number of infections per underlying disorder per year ESTIMATING THE BURDEN OF FUNGAL INFECTIONS IN MALAWI Khumbo Kalua1, Boston Zimba1 and David W. Denning2 1.Blantyre Institute for Community Outreach (BICO), Malawi 2.The University of Manchester and The National Aspergillosis Centre in association with the LIFE program at www.LIFE-Worldwide.org. Email – director@bicomalawi.org Table 1. Burden of fungal infections in Malawi Introduction Malawi is a small land locked densely populated poor country in the Southern part of Africa. As no serious attempt has been made to estimate the number of serious fungal infections in Malawi previously, we have attempted this, based on at risk population data and published rates. Infection Number of infections per underlying disorder per year Total burden Rate /100K None HIV/AIDS Respiratory Cancer/Tx ICU Cryptococcal Meningitis   12,000 80 Pneumocystis Pneumonia 10,800 72 Invasive Aspergillosis 90 0.6 Chronic pulmonary Apergillosis post TB 2,329 15.5 Allergic bronchopulmonary aspergillosis ABPA 14,010 93 Severe Asthma with fungal sensitization SAFS 18,493 123 Candideamia 525 225 750 5 Candida Peritonitis 113  113 0.75 Oral Candidiasis 432,000 2,880 Oesophageal Candidiasis 121,000 807 Recurrent Candida vaginitis (>_4x/year) 251,597 3,355 Mucormycosis 3  3 0.02 Histoplasmosis ?  Fungal keratitis 3,650  3,650 20.6 Tinea capitis 670,943  670,943 3,780 Total burden estimated 926,190 575,800 32,503 2,857 338 1,537,688 Methods A full literature search was done to identify all epidemiology papers reporting fungal infection rates from Malawi. We used specific populations at risk and fungal infection frequencies in the population to estimate national incidence or prevalence. Sources included the Malawi National statistical office (NSO), the Ministry of Health Population and Demographic survey of 2016, the 2015/16 HIV infection and AIDS rates from National Aids commission (NAC) WHO TB statistics, 2015; COPD rates from report Prevalence and future approach for prevention and control of Respiratory Diseases Results The Malawi population is approximately 17.7 million with 48% under 15 years of age. Approximately 8% of the population is HIV positive. The total estimated burden of fungal infections is 1,535,678. Among these, the most common infections are present in HIV/AIDS patients, with oral candidiasis (approximately 432,000 cases) being the commonest. Among common life threatening infections among the HIV/AIDS patients include cryptococcal meningitis (with 10% of AIDS patients presenting with the disease), and Pneumocystis pneumonia (9% of AIDS patients presenting with this). Pulmonary TB is present in approximately 11,000 cases per year, but extrapulmonary TB is rare. The prevalence of severe asthma with fungal sensitization SAFS is 14,010. Mucormycosis and histoplasmosis are rarely seen. Tinea capitis is estimated to be present in over 600,000 people. The incidence of fungal keratitis was estimated based on the annual number of cases seen in one department. African histoplasmosis (dubosiii), fungal keratitis, orbital mucormycosis and CPA with an aspergilloma Conclusion Fungal infections in Malawi are very common, and dominated by tinea capitis, recurrent vaginal candidiasis, oral and oesophageal candidiasis, and candidaemia. Among the most serious infections, cryptococcal meningitis and Pneumocystis pneumonia are on the top list. These basic estimates are limited, due to poor record data keeping, and require epidemiological studies to validate or modify the substantial burden. The number of reported cases of chromoblastomycosis in different countries (fromwww.gaffi.org/wp-content/uploads/chromobastomycosis-briefing-document-Nov-2014.pdf ) References 1. Msyamboza et al.: Burden of cancer in Malawi; common types, incidence and trends: National population-based cancer registry. BMC Research Notes 2012 5:149. 2. Lavy C, Tindall A, Steinlechner C, Mkandawire N, Chimangeni S. Surgery in Malawi – A National Survey of Activity in Rural and Urban Hospitals. annals. 2007 Oct 1;89(7):722–4. 3. Banda LT et al. Cancer incidence in Blantyre, Malawi 1994±1998. Tropical Medicine and International Health volume 6 no 4 pp 296±304 April 2001